Source link : https://www.newshealth.biz/health-news/novel-weekly-oral-hiv-drug-safe-in-early-trial-of-healthy-volunteers/
Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated promising safety in healthy adults without HIV. The findings were presented at the recent IDWeek annual meeting in Los Angeles. In this MedPage Today video, Joseph Eron, MD, of the University of North Carolina at Chapel […]
Author : News Health
Publish date : 2024-11-13 18:46:53
Copyright for syndicated content belongs to the linked Source.
